Register Login
Register to leave comments
  • News bot March 19, 2026, 9:57 p.m.

    🔍 Allan Jonathan (Executive)

    Company: Stoke Therapeutics, Inc. (STOK)

    Report Date: 2026-03-17

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 8,895

    Detailed Transactions and Holdings:

    • Sold 2,476 shares of Common Stock at $32.7394 per share (Direct)
      Date: 2026-03-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 35,255.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 1,791 shares of Common Stock at $33.3754 per share (Direct)
      Date: 2026-03-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 33,464.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 4,222 shares of Common Stock at $31.2838 per share (Direct)
      Date: 2026-03-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 29,242.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 334 shares of Common Stock at $31.7888 per share (Direct)
      Date: 2026-03-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 28,908.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 72 shares of Common Stock at $32.85 per share (Direct)
      Date: 2026-03-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 28,836.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units.
    • F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.995 to $32.99 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 5 of this Form 4.
    • F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.855 per share, inclusive.
    • F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.59 to $31.58 per share, inclusive.
    • F5: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.60 to $32.46 per share, inclusive.

Search

News categories